Differential expression of nitric oxide synthase in experimental uveoretinitis

Investigative Ophthalmology and Visual Science

Volumn 40, Issue 9, 1999, Pages 1899-1905

  Zhang, Jie ^a   Wu, Lan Ying ^a   Wu, Guey Shuang ^a   Rao, Narsing A ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b DOHENY EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERFERON; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; MYELIN BASIC PROTEIN; NITRIC OXIDE SYNTHASE; PROTEIN; RETINA S ANTIGEN; RETINOID BINDING PROTEIN; VISUAL PIGMENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; FROZEN SECTION; HYBRIDIZATION; IMMUNOHISTOCHEMISTRY; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SENSITIZATION; UVEORETINITIS;

ANIMALS; ARRESTIN; BLOTTING, NORTHERN; CATTLE; CELLS, CULTURED; EYE PROTEINS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; MACROPHAGES; MICE; MYELIN BASIC PROTEINS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RABBITS; RATS; RATS, INBRED LEW; RETINITIS; RETINOL-BINDING PROTEINS; RNA, MESSENGER; SERUM ALBUMIN, BOVINE; UVEITIS;

EID: 0032868271     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Kroncke KD, Fehsel K, Kolb-Bachofen V. Nitric oxide: cytotoxicity versus cytoprotection: how, why, when and where? Nitric Oxide. 1997;1:107-120
2. Mandai M, Yoshimura N, Yoshida M, Iwaki M, Honda Y. The role of nitric oxide synthase in endotoxin-induced uveitis: effects of NG-nitro L-arginine. Invest Ophthalmol Vis Sci. 1994;35:3673-3680.
3. Parks DJ, Cheung MK, Chan CC, Roberge FG. The role of nitric oxide in uveitis. Arch Ophthalmol. 1994;112:544-546.
4. Goureau O, Bellot J, Thillaye B, Courtois Y, de Kozak Y. Increased nitric oxide production in endotoxin-induced uveitis. Reduction of uveitis by an inhibitor of nitric oxide synthase. J Immunol. 1995; 154:6518-6523.
5. McCartney-Francis N, Allen JB, Mizel DE, et al. Suppression of arthritis by an inhibitor of nitric oxide synthase. J Exp Med. 1993; 178:749-754.
6. Koprowski H, Zheng YM, Heber-Katz E, et al. In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases. Proc Natl Acad Sci USA. 1993;90:3024-3027.
7. Rao NA. Role of oxygen free radicals in retinal damage associated with experimental uveitis. Trans Am Ophthalmol Soc. 1990;88: 797-850.
8. Wu GS, Zhang J, Rao NA. Peroxynitrite and oxidative damage in experimental autoimmune uveitis. Invest Ophthalmol Vis Sci. 1997;38:1333-1339.
9. Yamaki K, Tsuda M, Shinohara T. The sequence of human retinal S-antigen reveals similarities with α-transducin. FEBS Lett. 1988; 234:39-43.
10. Doroso LA, Merryman CF, Sery TW, et al. S-antigen: characterization of a pathogenic epitope which mediates experimental autoimmune uveitis and pinealitis in Lewis tats. Curr Eye Res. 1987;6: 1151-1159.
11. Fong SL, Liou GI, Landers RA, Alvarez RA, Bridges CD. Purification and characterization of a retinol-binding glycoprotein synthesized and secreted by bovine neural retina. J Biol Chem. 1984;259: 6534-6542.
12. Hoey S, Grabowski PS, Ralson SH, Forrester JV, Liversidge J. Nitric oxide accelerates the onset and increases the severity of experimental autoimmune uveoretinitis through an IFN-γ-dependent mechanism. J Immunol. 1997;159:5132-5142.
13. Yu SF, Koerner TJ, Adams DO. Gene regulation in macrophage activation: differential regulation of genes encoding for tumor necrosis factor, interleukin-1, JE, and KC by interferon-gamma and lipopolysaccharide. J Leukoc Biol. 1990;48:412-419.
14. Vodovotz Y, Bogdan C. Control of nitric oxide synthase expression by transforming growth factor-beta: implications for homeostasis. Prog Growth Factor Res. 1994;5:341-351.
15. Vodovotz Y, Letterio JJ, Geiser AG, Chesler L, Roberts AB, Sparrow J. Control of nitric oxide production by endogenous TGF-betal and systemic nitric oxide in retinal pigment epithelial cells and peritoneal macrophages. J Leukoc Biol. 1996;60:261-270.
16. Ding A, Nathan CF, Graycar J, Derynck R, Stuehr DJ, Srimal S. Macrophage deactivating factor and transforming growth factors-β1, -β2 and β3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-gamma. J Immunol. 1990;145:940-944.
17. Pfeilschifter J, Vosbeck K. Transforming growth factor β2 inhibits interleukin 1β- and tumor necrosis factor α-induction of nitric oxide synthase in rat renal mesangial cells. Biochem Biophys Res Commun. 1991;175:372-379.
18. Roberts AB, Vodovotz Y, Roche NS, Sporn MB, Nathan CF. Role of nitric oxide in antagonistic effects of transforming growth factor-β and interleukin-1β on the beating rate of cultured cardiac myocytes. Mol Endocrinol. 1992;6:1921-1930.
19. Anderson DH, Guerin CJ, Hageman GS, Pfeffer BA, Flanders KC. Distribution of transforming growth factor-β isoforms in the mammalian retina. J Neurosci Res. 1995;42:63-79.
20. Pasquale LR, Dorman-Pease ME, Lutty GA, Quigley HA, Jampel HD. Immunolocalization of TGF-β1, TGF-β2, and TGF-β3 in the anterior segment of the human eye. Invest Ophthalmol Vis Sci. 1993;34:23-30.
21. Lopez-Moratalla N, Calleja A, Gonzalez A, et al. Inducible nitric oxide synthase in monocytes from patients with Graves' disease. Biochem. Biophys Res Commun. 1996;226:723-729.
22. Mosley K, Cuzner ML. Receptor-mediated phagocytosis of myelin by macrophages and microglia: effect of opsonization and receptor blocking agents. Neurochem Res. 1996;21:481-487.